Aditxt Inc. (ADTX) - Total Liabilities
Based on the latest financial reports, Aditxt Inc. (ADTX) has total liabilities worth $49.08 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Aditxt Inc. to track the company's year-over-year net asset growth rate.
Aditxt Inc. - Total Liabilities Trend (2017–2025)
This chart illustrates how Aditxt Inc. 's total liabilities have evolved over time, based on quarterly financial data. See Aditxt Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Aditxt Inc. Competitors by Total Liabilities
The table below lists competitors of Aditxt Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SOL GLOBAL INVESTM. CORP
F:9SB
|
Germany | €6.42 Million |
|
Taiwan Styrene Monomer Corp
TW:1310
|
Taiwan | NT$2.37 Billion |
|
SDM SE
XETRA:75S
|
Germany | €12.80 Million |
|
SDM SE INH O.N.
F:75S
|
Germany | €12.80 Million |
|
Hannun SA
MC:HAN
|
Spain | €3.18 Million |
|
Bank JTrust Indonesia Tbk PT
JK:BCIC
|
Indonesia | Rp37.02 Trillion |
|
Landsea Homes Corporation
NASDAQ:LSEAW
|
USA | $1.01 Billion |
Liability Composition Analysis (2017–2025)
This chart breaks down Aditxt Inc. 's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ADTX market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aditxt Inc. 's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aditxt Inc. (2017–2025)
The table below shows the annual total liabilities of Aditxt Inc. from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $12.56 Million | -47.34% |
| 2024-12-31 | $23.86 Million | -16.38% |
| 2023-12-31 | $28.53 Million | +416.04% |
| 2022-12-31 | $5.53 Million | -14.72% |
| 2021-12-31 | $6.48 Million | +210.94% |
| 2020-12-31 | $2.09 Million | -29.93% |
| 2019-12-31 | $2.98 Million | +80.08% |
| 2018-12-31 | $1.65 Million | +1846.34% |
| 2017-12-31 | $84.90K | -- |
About Aditxt Inc.
Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body nat… Read more